Abstract
Objective
To assess the effect of Shenmai Injection (参麦注射液, SMI) on left ventricular diastolic function (LVDF) in patients with chronic heart failure (CHF) by tissue Doppler imaging (TDI).
Methods
Sixty-four CHF patients were randomly assigned to two groups, the observation group and the control group. Basic treatment including polarized liquid therapy was given to all the patients. In addition, SMI was given to patients of the observation group. The treatment duration was 14 days. TDI was performed in all the patients 3 days prior to the initiation of the treatment and one week after the medication to measure the average movement velocity of the mitral ring of the left ventricle at the early systolic stage and late diastolic stage (Ea and Aa); the outcomes were compared with the corresponding parameters obtained from blood flow Doppler echocardiography, namely, the velocity of the E-wave (E) and A-wave (A).
Results
After treatment, Ea and Ea/Aa increased and Aa decreased significantly in the observation group (P<0.05). In the control group, although some improvement was seen, there was no statistically significant change (P>0.05). No statistical significance was shown between groups in these parameters after treatment.
Conclusion
TDI assessment shows that SMI could effectively improve the LVDF in CHF patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol 1999;33:1948–1955.
Fox JM, Maurer MS. Ventriculovascular coupling in systolic and diastolic heart failure. Curr Heart Fail Rep 2005;2:204–211.
Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:e1–82.
Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 2006;48:1548–1551.
Chon JN. Physiological rationale for co-treatment with diuretics in Heart failure. Br Heart 1994;72:S63–67.
Kindermann M, Reil JC, Pieske B, van Veldhuisen DJ, Bohm M. Heart failure with normal left ventricular ejection fraction: what is the evidence? Trends Cardiovasc Med 2008;18:280–292.
Ma L, Yang L, Chen TD. Influence of large amount of Shenmai Injection on blood coagulation in patients with chronic heart failure. Chin J Tradit West Med (Chin) 2003;23:275–277.
Wang HY, Yu BY, Yan YQ. Modulation of saponins extracted from Shenmai Powder on free calcium ion in cultured rat myocardial cells. Chin J Tradit West Med (Chin) 2002;22:848–850.
di-Bello V, Giorgi D, Pedrinelli R, Talini E, Palagi C, Delle Donne MG, et al. Left ventricular hypertrophy and its regression in essential arterial hypertension—A tissue Doppler imaging study. Am J Hypertens 2004;17:882–890.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ma, Rg., Wang, Cx., Shen, Yh. et al. Effect of Shenmai Injection (参麦注射液) on ventricular diastolic function in patients with chronic heart failure: An assessment by tissue Doppler imaging. Chin. J. Integr. Med. 16, 173–175 (2010). https://doi.org/10.1007/s11655-010-0173-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-010-0173-1